Original Research
Accepted on 22 Apr 2025
Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study
in Hematologic Malignancies
- 123 views
Original Research
Accepted on 22 Apr 2025
in Hematologic Malignancies
Original Research
Accepted on 22 Apr 2025
in Hematologic Malignancies
Case Report
Accepted on 22 Apr 2025
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Accepted on 22 Apr 2025
in Cancer Imaging and Image-directed Interventions
Original Research
Accepted on 22 Apr 2025
in Head and Neck Cancer
Original Research
Accepted on 22 Apr 2025
in Cancer Imaging and Image-directed Interventions
Original Research
Accepted on 22 Apr 2025
in Cancer Molecular Targets and Therapeutics
Systematic Review
Accepted on 22 Apr 2025
in Head and Neck Cancer
Systematic Review
Accepted on 22 Apr 2025
in Radiation Oncology
Original Research
Accepted on 22 Apr 2025
in Radiation Oncology
Case Report
Accepted on 22 Apr 2025
in Genitourinary Oncology
Review
Accepted on 22 Apr 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 22 Apr 2025
in Gastrointestinal Cancers: Colorectal Cancer
Review
Accepted on 22 Apr 2025
in Cancer Epidemiology and Prevention
Original Research
Accepted on 22 Apr 2025
in Gynecological Oncology
Mini Review
Accepted on 22 Apr 2025
in Cancer Molecular Targets and Therapeutics